These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3306202)

  • 1. Hypertension in blacks.
    Saunders E
    Med Clin North Am; 1987 Sep; 71(5):1013-29. PubMed ID: 3306202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment considerations for the hypertensive black patient.
    Saunders E
    J Fam Pract; 1988 Jun; 26(6):659-64. PubMed ID: 3288707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in blacks.
    Saunders E
    Prim Care; 1991 Sep; 18(3):607-22. PubMed ID: 1946790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension in the Negro patient].
    Timmers GJ; Schouten JA; ter Wee PM; Gans RO
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):229-34. PubMed ID: 10086150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and hypertension. What is clinically relevant?
    Rutledge DR
    Drugs; 1994 Jun; 47(6):914-32. PubMed ID: 7521831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.
    Flack JM; Hamaty M
    J Hypertens Suppl; 1999 Feb; 17(1):S19-24. PubMed ID: 10340840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
    Freis ED
    Prog Clin Biol Res; 1986; 214():313-22. PubMed ID: 3523510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient.
    Cook CA
    Am Heart J; 1988 Jul; 116(1 Pt 2):288-95. PubMed ID: 2899388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and risk of renal cell carcinoma among white and black Americans.
    Colt JS; Schwartz K; Graubard BI; Davis F; Ruterbusch J; DiGaetano R; Purdue M; Rothman N; Wacholder S; Chow WH
    Epidemiology; 2011 Nov; 22(6):797-804. PubMed ID: 21881515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake.
    Weir MR; Smith DH; Neutel JM; Bedigian MP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):665-71. PubMed ID: 11465651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring treatment to minority patients.
    Saunders E
    Am J Med; 1990 Mar; 88(3B):21S-23S. PubMed ID: 2180289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
    Hebert LA; Agarwal G; Ladson-Wofford SE; Reif M; Hiremath L; Carlton SG; Nahman NS; Falkenhain ME; Agarwal A
    J Am Soc Nephrol; 1996 Oct; 7(10):2130-4. PubMed ID: 8915972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.
    M'Buyamba-Kabangu JR; Tambwe M
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():389-94. PubMed ID: 1980202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors.
    Shulman NB
    J Natl Med Assoc; 1988 Mar; 80(3):265-72. PubMed ID: 3280812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to treat hypertension in blacks: review of the evidence.
    Kola LD; Sumaili EK; Krzesinski JM
    Acta Clin Belg; 2009; 64(6):466-76. PubMed ID: 20101869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of systemic hypertension in blacks.
    Weir MR; Saunders E
    Am J Cardiol; 1988 Jun; 61(16):46H-52H. PubMed ID: 3289351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial.
    Odili AN; Richart T; Thijs L; Kingue S; Boombhi HJ; Lemogoum D; Kaptue J; Kamdem MK; Mipinda JB; Omotoso BA; Kolo PM; Aderibigbe A; Ulasi II; Anisiuba BC; Ijoma CK; Ba SA; Ndiaye MB; Staessen JA; M'buyamba-Kabangu JR;
    Blood Press; 2011 Oct; 20(5):256-66. PubMed ID: 21495829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.
    Gharaibeh KA; Turner ST; Hamadah AM; Chapman AB; Cooper-Dehoff RM; Johnson JA; Gums JG; Bailey KR; Schwartz GL
    Am J Hypertens; 2016 Oct; 29(10):1186-94. PubMed ID: 27365079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.